Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780541 ·Status: TERMINATED ·Phase: PHASE3

To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)

NCT04541485 ·Status: TERMINATED ·Phase: PHASE1

A Trial of Remdesivir in Adults With Mild and Moderate COVID-19

NCT04252664 ·Status: SUSPENDED ·Phase: PHASE3

Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia

NCT04679350 ·Status: TERMINATED ·Phase: PHASE2

JT001 (VV116) for the Early Treatment of COVID-19

NCT05242042 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

NCT05758519 ·Status: UNKNOWN ·Phase: PHASE3

Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19

NCT04467151 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19

NCT04730427 ·Status: TERMINATED ·Phase: PHASE1

A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

NCT04906980 ·Status: TERMINATED ·Phase: PHASE2

Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection

NCT04784559 ·Status: TERMINATED ·Phase: PHASE3

Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)

NCT04487886 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

NCT04745351 ·Status: TERMINATED ·Phase: PHASE3

Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314

NCT04871646 ·Status: UNKNOWN ·Phase: PHASE3

Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers

NCT04328285 ·Status: TERMINATED ·Phase: PHASE3

Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections

NCT04365725 ·Status: COMPLETED

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

NCT05689203 ·Status: UNKNOWN ·Phase: PHASE2

Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness

NCT05603143 ·Status: TERMINATED ·Phase: PHASE3

The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19

NCT04891302 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19

NCT04805671 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

NCT05947812 ·Status: UNKNOWN ·Phase: PHASE2

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780463 ·Status: COMPLETED ·Phase: PHASE3

The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

NCT04347915 ·Status: COMPLETED ·Phase: PHASE2

Defibrotide for the Treatment of Severe COVID-19

NCT04652115 ·Status: RECRUITING ·Phase: PHASE2

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3